AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India · Delayed Price · Currency is INR 8,419.00
-14.00 (-0.17%)
Aug 25, 2025, 9:30 AM IST
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 210.79 billion as of August 22, 2025. Its market cap has increased by 20.92% in one year.
Market Cap
210.79B
Enterprise Value
205.79B
Revenue
18.55B
Ranking
n/a
PE Ratio
114.96
Stock Price
8,419.00
Market Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 210.79B, an increase of 14,437.33%. That is a compound annual growth rate of 23.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 210.79B | 15.35% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | 115.54B | 76.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,939.23B |
| Divi's Laboratories | 1,633.03B |
| Cipla | 1,286.59B |
| Apollo Hospitals Enterprise | 1,139.13B |
| Mankind Pharma | 1,075.90B |
| Zydus Lifesciences | 994.96B |
| Fortis Healthcare | 705.43B |
| Alkem Laboratories | 648.76B |